Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapyJustyna Czapla, Ryszard Smolarczyk|Cancer Immunology Immunotherapy|2024Cited by 14
Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes StatusesAlina Drzyzga, Ryszard Smolarczyk|Cancers|2025Cited by 2